DUBLIN--(BUSINESS WIRE)--The "Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
According to this report the global Femtech market generated a revenue of $820.6 million in 2019 and is estimated to grow over $3.04 billion by the end of 2030.
The market is projected to grow at a CAGR of 12.65%, during the forecast period. There are multiple factors that drive the market such as increasing representation of women in the technological community, raising awareness of women's health, growing prevalence of infectious diseases among females in low to middle-income countries, and a surge in funding activities, among others.
Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.
However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million funding (till 2019). The number of women-centric startups have significantly multiplied in recent years. This surge is also primarily attributed to the launch of the fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.
Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care, and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering financial support of $23 million.
Currently, the Femtech industry comprises over 200 start-ups globally, and a significant number of such companies are being led by women. Some of the major areas of women's health that are being catered to with the help of technology are menstruation care, sexual health, fertility, and pregnancy care. Within these areas, companies are either developing new solutions such as Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker or focusing on technology-based platforms using subscription-based model to democratize existing products such as birth control products and period products.
- Growing recognition of Women in the Domain of Technology
- Economic Burden of Women's health is more than $500 Billion
- Explosion of wearable devices and increasing smartphone penetration among women
- Lack of women decision makers
- Societal taboos surrounding women's health issues
- Absence of awareness among women in rural areas
- Lack of scientific studies to back industrial claims
- Investment in product development for maternal, pre- and neo-natal care
- Investment in sub-Saharan Africa
- Product development for menopause management
Key Questions Answered:
- How has the market evolved in the last five years, and what are the awaited technological advancements in the field of Femtech?
- What are the major market drivers, challenges, and opportunities in the global Femtech market?
- What are the underlying structures resulting in the emerging trends within the Femtech industry?
- What was the market value of the leading segments of the global Femtech market in 2019?
- What are the influencing factors that may affect the market positioning of the key players?
- How is the industry expected to evolve during the forecast period 2019-2030?
- What are the key developmental strategies which are implemented by the key players to sustain in the competitive market?
- What are the key business models employed by the femtech companies to standout in the evolving market?
- What is the growth potential of Femtech in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
- What are the key regulatory implications in developed and developing regions for Femtech?
- What were the funding trends for the Femtech companies in the last three years and how would the funding scenario change during the forecast period?
- ALYK, Inc.
- Aytu BioScience, Inc.
- Biowink GmbH
- Flo Health, Inc.
- Glow, Inc.
- NaturalCycles Nordic AB
- Ovia Health
- Plackal Tech
- Sustain Natural
- The Flex Company
- Thinx, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9oa79u